IP Verse

Boehringer Ingelheim patent opposition analysis

Get complete Patent Opposition Report for Boehringer Ingelheim

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Boehringer Ingelheim

Explore patent oppositions filed by Boehringer Ingelheim against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP41071595-(3-(Ethylsulfonyl)Pyridin-2-Yl)-Pyrazolo[1,5-A]Pyrimidine Derivatives And Related Compounds As Pesticide And Insecticide Agents For Crop ProtectionPI INDUSTRIESJan 16, 2025
EP3300743Methods Of Vaccine AdministrationZOETIS SERVICESMar 13, 2024
EP3733672Heterocyclic Compounds And Noxious Arthropod Control Agent Containing SameSUMITOMO CHEMICALDec 20, 2023
EP3471766Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Infectious Bursal Disease Virus AntigensINTERVETSep 12, 2023
EP3165600Cell Culture Medium Comprising Small PeptidesLIFEAug 1, 2023
EP2833908Mycoplasma Hyopneumoniae VaccineZOETISOct 3, 2022
EP3342786Anti-Dll3 AntibodyCHUGAI SEIYAKU KABUSHIKI KAISHAMar 22, 2022
EP3541387Dose And Regimen For Hdm2-P53 Interaction InhibitorsNOVARTISJan 20, 2022
EP2970916Adapted Lepidopteran Insect Cells For The Production Of Recombinant ProteinsMERCK SHARP & DOHMEJan 14, 2022
EP2994162Vaccine For Pcv2 And MycoplasmaPHARMGATE BIOLOGICSJan 7, 2022

Latest patents of Boehringer Ingelheim opposed by its competitors

Explore Boehringer Ingelheim's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2488145Apr 24, 2024Containers For Compositions Comprising Meloxicam1
EP3150200Apr 10, 2024Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses Thereof4
EP2395968Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient18
EP2313087Nov 22, 2023Pharmaceutical Dosage Form For Immediate Release Of An Indolinone Derivative3
EP3862003Oct 25, 2023An Sglt-2 Inhibitor For Use In The Treatment Of A Metabolic Disorder In Feline Animals1
EP3110449Jun 28, 2023Medical Use Of A Dpp-4 Inhibitor5
EP3485890May 10, 2023Treatment Of Metabolic Disorders In Canine Animals1
EP3802922Apr 26, 2023Novel Immune Checkpoint Inhibitors1
EP3534939Feb 22, 2023Vaccine Against Porcine Parvovirus And Porcine Reproductive And Respiratory Syndrome Virus And Methods Of Production Thereof1
EP3362055Jan 18, 2023Sglt-2 Inhibitor For Use In The Treatment Of A Metabolic Myopathy2

Top competitors of Boehringer Ingelheim